Vivek Kumar Garg - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Vivek Kumar Garg

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

Oncotargets and Therapy|December 7, 2022

Licorice (<i>Glycyrrhiza glabra</i> L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic EffectsHardeep Singh Tuli, Vivek Kumar Garg, Jinit K Mehta, et al.

Indian Journal of Pharmacology|December 7, 2020

Presence of allele CYP3A4*16 does not have any bearing on carbamazepine-induced adverse drug reactions in North Indian people with epilepsyVivek Kumar Garg, Manoj Kumar Goyal, Madhu Khullar, et al.

Toxicology Reports|December 23, 2022

Ampelopsin targets in cellular processes of cancer: Recent trends and advancesHardeep Singh Tuli, Katrin Sak, Vivek Kumar Garg, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

Oncotargets and Therapy|December 7, 2022

Indian Journal of Pharmacology|December 7, 2020

Presence of allele CYP3A4*16 does not have any bearing on carbamazepine-induced adverse drug reactions in North Indian people with epilepsyVivek Kumar Garg, Manoj Kumar Goyal, Madhu Khullar, et al.

Toxicology Reports|December 23, 2022

Ampelopsin targets in cellular processes of cancer: Recent trends and advancesHardeep Singh Tuli, Katrin Sak, Vivek Kumar Garg, et al.

Pageof 5